As of 2025-08-27, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -25.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 671.77 mil USD. MRVI's TTM EBITDA according to its financial statements is -26.51 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 14.4x | 12.9x |
| Forward P/E multiples | 15.0x - 22.6x | 18.8x |
| Fair Price | (1.78) - (1.72) | (1.87) |
| Upside | -173.7% - -171.0% | -177.1% |
| Date | EV/EBITDA |
| 2025-08-27 | -24.34 |
| 2025-08-26 | -25.34 |
| 2025-08-25 | -25.15 |
| 2025-08-22 | -25.63 |
| 2025-08-21 | -25.06 |
| 2025-08-20 | -25.73 |
| 2025-08-19 | -26.21 |
| 2025-08-18 | -26.79 |
| 2025-08-15 | -27.17 |
| 2025-08-14 | -27.07 |
| 2025-08-13 | -28.51 |
| 2025-08-12 | -27.94 |
| 2025-08-11 | -21.89 |
| 2025-08-08 | -23.23 |
| 2025-08-07 | -21.55 |
| 2025-08-06 | -21.65 |
| 2025-08-05 | -24.58 |
| 2025-08-04 | -23.90 |
| 2025-08-01 | -23.42 |
| 2025-07-31 | -24.58 |
| 2025-07-30 | -25.25 |
| 2025-07-29 | -25.92 |
| 2025-07-28 | -27.55 |
| 2025-07-25 | -27.94 |
| 2025-07-24 | -28.13 |
| 2025-07-23 | -27.27 |
| 2025-07-22 | -26.40 |
| 2025-07-21 | -24.96 |
| 2025-07-18 | -25.44 |
| 2025-07-17 | -26.21 |
| 2025-07-16 | -26.30 |
| 2025-07-15 | -26.98 |
| 2025-07-14 | -27.75 |
| 2025-07-11 | -28.32 |
| 2025-07-10 | -29.86 |
| 2025-07-09 | -28.61 |
| 2025-07-08 | -28.61 |
| 2025-07-07 | -27.07 |
| 2025-07-03 | -27.75 |
| 2025-07-02 | -27.55 |
| 2025-07-01 | -26.21 |
| 2025-06-30 | -25.25 |
| 2025-06-27 | -25.82 |
| 2025-06-26 | -24.96 |
| 2025-06-25 | -23.90 |
| 2025-06-24 | -23.52 |
| 2025-06-23 | -22.37 |
| 2025-06-20 | -21.89 |
| 2025-06-18 | -21.41 |
| 2025-06-17 | -22.17 |